FDA Inspection 701781 — OneBlood, Inc.

OneBlood, Inc. — FEI 1070206

The FDA completed an inspection of OneBlood, Inc. on December 3, 2010 in Ocala, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 3, 2010
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ocala, FL (United States)

Citations

IDCFRDescription
1220221 CFR 606.170(a)Adverse Reaction - Investigations
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs